![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Protherics (MM) | NASDAQ:PTIL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.30 | 0 | 01:00:00 |
PROTHERICS PLC Notification of Interim Results London, UK; Brentwood, TN, US; 12 November 2008: Protherics PLC ("Protherics"), the biopharmaceutical company focused on critical care and cancer, will be announcing its interim results for the six months ended 30 September 2008, on Thursday 20 November 2008. Enquiries: Protherics PLC +44 (0) 20 7246 9950 Nick Staples, Corporate Affairs Financial Dynamics +44 (0) 20 7831 3113 Mo Noonan This information is provided by RNS The company news service from the London Stock Exchange END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact http://www.rns.com
1 Year Protherics Chart |
1 Month Protherics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions